Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6064815 | Journal of Allergy and Clinical Immunology | 2014 | 11 Pages |
Abstract
Pharmacogenetics is being used to develop personalized therapies specific to subjects from different ethnic or racial groups. To date, pharmacogenetic studies have been primarily performed in trial cohorts consisting of non-Hispanic white subjects of European descent. A “bottleneck” or collapse of genetic diversity associated with the first human colonization of Europe during the Upper Paleolithic period, followed by the recent mixing of African, European, and Native American ancestries, has resulted in different ethnic groups with varying degrees of genetic diversity. Differences in genetic ancestry might introduce genetic variation, which has the potential to alter the therapeutic efficacy of commonly used asthma therapies, such as β2-adrenergic receptor agonists (β-agonists). Pharmacogenetic studies of admixed ethnic groups have been limited to small candidate gene association studies, of which the best example is the gene coding for the receptor target of β-agonist therapy, the β2-adrenergic receptor (ADRB2). Large consortium-based sequencing studies are using next-generation whole-genome sequencing to provide a diverse genome map of different admixed populations, which can be used for future pharmacogenetic studies. These studies will include candidate gene studies, genome-wide association studies, and whole-genome admixture-based approaches that account for ancestral genetic structure, complex haplotypes, gene-gene interactions, and rare variants to detect and replicate novel pharmacogenetic loci.
Keywords
ADRB1GRK5SABAADRB2ICSNIHNHLBIPEFRAsthmaLong-acting β-agonistShort-acting β-agonistBadgerBARGELARGEpeak expiratory flow rateGenesLABAPharmacogeneticsNational Heart, Lung, and Blood InstituteNIH, National Institutes of HealthGenome-wide association studyGWASAdmixture mappingSMARTSingle nucleotide polymorphismSNPGenetics of Asthma in Latino AmericansInhaled corticosteroidGalAEthnic groupβ1-Adrenergic receptorβ2-adrenergic receptor
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Victor E. MD, Deborah A. PhD,